cbdMD, Inc.

YCBD
NYSEPerfumes, Cosmetics & Other Toilet PreparationsNC

-6.2%

since IPO

IPO Price

$0.97

Current Price

$0.91

Return

-6.2%

Market Cap

$9.6M

IPO Date

Mar 4, 2026

Lockup End

Aug 31, 2026

Lockup Status

124days until lockup expires

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price
IPO Price
Lockup End

Performance Summary

First Day
N/A
1 Month
N/A
3 Months
N/A
6 Months
N/A
1 Year
N/A
Since IPO
-6.2%

cbdMD, Inc. (YCBD) — IPO Analysis

By Kian O Connor | Updated 4/29/2026

Company Overview

cbdMD, Inc. (ticker: YCBD) operates in specialized business operations focused on market development and competitive positioning, establishing itself as a notable participant in the specialized sector. Based in NC and positioned within the evolving market landscape, the company has developed its operations during a period of industry evolution, technological advancement, and market development and competitive market development. With $10 million in market value, cbdMD, Inc. focuses on operational excellence, market focus, and strategic execution while building stakeholder value through strategic execution and market positioning. The company completed its initial public offering on March 04, 2026, pricing shares at $0.97 each during market evolution and focus on sustainable competitive advantages. The IPO faced mixed institutional reception, reflecting market assessment of the company's positioning within the specialized sector and growth prospects. The offering positioned the company to access public capital markets while providing investors with exposure to its operations and strategic development. Market reception reflected investor evaluation of competitive advantages, market positioning, and execution capabilities as key factors in the company's long-term value creation potential. Post-IPO performance has navigated market challenges, with the stock currently trading at $0.91, representing a decline of -6.19% from the IPO price. This market execution and competitive positioning demonstrates ongoing investor evaluation in the company's strategic execution within the specialized sector. The market adjustment reflects investor evaluation of market positioning, operational execution, and competitive development as critical factors in assessing competitive positioning and sustainable value creation capabilities. Looking ahead, cbdMD, Inc.'s lockup period is scheduled to expire August 31, 2026. Given the company's positioning within the specialized sector and its performance trajectory since going public, the lockup expiration will provide valuable insights into management and early investor confidence in strategic direction. The operational characteristics of companies focused on specialized business operations focused on market development and competitive positioning mean that insider decisions often reflect comprehensive assessments of market positioning, operational execution, and competitive development rather than short-term market fluctuations. The lockup milestone indicates management's confidence in executing strategic objectives and creating sustainable value through operational excellence, market focus, and strategic execution within the competitive market landscape.

Performance Overview

Since going public at $0.97 per share on Mar 4, 2026, cbdMD, Inc. shares have declined 6.2%, disappointing investors who participated in the IPO. The stock currently trades at $0.91, giving the company a market capitalization of $9.6M.

Lockup Expiration

The lockup period for cbdMD, Inc. insiders is set to expire on Aug 31, 2026, which is 124 days from now. When the lockup expires, insiders and early investors who received shares before the IPO will be free to sell their holdings on the open market. This can create significant selling pressure and is closely watched by traders and institutional investors alike.

Industry Context

cbdMD, Inc. operates in the Perfumes, Cosmetics & Other Toilet Preparations sector, which has seen varied IPO activity in recent years. The company is headquartered in NC and is classified under SIC code 2844. Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing YCBD as an investment.

Trading History

cbdMD, Inc. is actively trading in the public markets with a current share price of $0.91. The company went public at $0.97 per share, representing a decline of 6.2% from the initial offering price. With a current market capitalization of $9.6M, cbdMD, Inc. continues to establish its presence as a publicly traded entity in the Perfumes, Cosmetics & Other Toilet Preparations.

Important Disclaimer

This analysis of cbdMD, Inc. (YCBD) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

2
Pre-Expiry Average
Minimal
93
Expiry Day
Very High
57
Post-Expiry (30d)
High

Activity Heatmap

60 days before/after lockup expiry
Intensity Scale:
Minimal
Low
Moderate
High
Very High
Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Related IPOs

TickerCompanyIndustryIPO DateIPO PriceCurrentReturn
SWRDStewards, Inc.Short-Term Business Credit InstitutionsApr 28, 2026$2.71$2.60-4.1%
COAGHemab Therapeutics Holdings, Inc.Biological Products, (No Diagnostic Substances)Apr 28, 2026N/AN/AN/A
REARare Earths Americas, Inc.Metal MiningApr 28, 2026N/AN/AN/A
QLEPQuantum Leap Acquisition CorpBlank ChecksApr 28, 2026N/AN/AN/A
ASFHASIAFIN HOLDINGS CORP.Services-Business Services, NECApr 28, 2026$0.51$0.51+0.0%
GMRSGMR Solutions Inc.Transportation ServicesApr 28, 2026N/AN/AN/A
IACQIrenic Acquisition Corp.Blank ChecksApr 28, 2026N/AN/AN/A
CXIIChurchill Capital Corp XIIBlank ChecksApr 28, 2026N/AN/AN/A

Related IPO Analysis

KO
By • Founder & Data Analyst